NTRK1 and glioblastoma: TRKA is overexpressed in various cancers including pancreas, breast, lung, glioblastoma, lymphoid, oral squamous cell carcinoma, and adenoid cystic carcinoma and confers drug resistance and poor prognosis.51, 52